NCT00215202 2018-05-17Phase II Trial of ZD1839 (Iressa) in Patients With Nonresectable Adrenocortical Carcinoma (ACC)Dartmouth-Hitchcock Medical CenterPhase 2 Completed16 enrolled
NCT00095836 2017-05-31Gefitinib in Treating Patients With Locally Advanced or Metastatic Thyroid Cancer That Did Not Respond to Iodine TherapyMassachusetts General HospitalPhase 2 Completed27 enrolled 16 charts